Explore the categories so you can find more about your search.

Categorie > Cancer / Oncology

Cancer And Health Care Disparities Among Minority Women - American Medical Association

Categorie : Cancer / Oncology
The American Medical Association (AMA), the nation's largest physician group, voted at its Annual Meeting to adopt the following new policy.According to the National Cancer Institute, minority women have a significantly higher cancer mortality rate than Caucasian women. ...

read more The American Medical Association (AMA), the nation's largest physician group, voted at its Annual Meeting to adopt the following new policy.According to the National Cancer Institute, minority women have a significantly higher cancer mortality rate than Caucasian women. read more Thu Jun 2008 Thu Jun 2008

The Predictors Of Local Recurrence After Radical Cystectomy In Patients With Invasive Bladder Cancer

Categorie : Cancer / Oncology
UroToday.com - Although radical cystectomy has been considered the gold standard curative treatment for invasive bladder cancer, around one third of the patients relapse and die of the disease after surgery. The main reason for cancer death in patients treated with radical cystectomy has been associ ...

read more UroToday.com - Although radical cystectomy has been considered the gold standard curative treatment for invasive bladder cancer, around one third of the patients relapse and die of the disease after surgery. The main reason for cancer death in patients treated with radical cystectomy has been associ read more Thu Jun 2008 Thu Jun 2008

Focus On The Genetics Of Brain Tumor Formation Identifies Potential New Neuronal Tumor Suppressor

Categorie : Cancer / Oncology
In a G&D paper published online ahead of its April 1 print publication date, Dr. William Kaelin (Dana Farber Cancer Institute) and colleagues identify a potential new neuronal tumor suppressor."It has been suspected for decades that the short arm of chromosome 1 harbored one or more tumor suppressor ...

read more In a G&D paper published online ahead of its April 1 print publication date, Dr. William Kaelin (Dana Farber Cancer Institute) and colleagues identify a potential new neuronal tumor suppressor. read more Tue Mar 2008 Tue Mar 2008

AACR Funds Minority And Underrepresented Scientists

Categorie : Cancer / Oncology
Minorities in Cancer Research (MICR), a 3,000-member group within the American Association for Cancer Research (AACR), has selected the winners of two scholar awards for scientists working in underrepresented areas of the cancer research community. ...

read more Minorities in Cancer Research (MICR), a 3,000-member group within the American Association for Cancer Research (AACR), has selected the winners of two scholar awards for scientists working in underrepresented areas of the cancer research community. read more Tue Mar 2008 Tue Mar 2008

Harald Zur Hausen Receives American Association For Cancer Research Lifetime Achievement Award

Categorie : Cancer / Oncology
Harald zur Hausen, D.Sc., M.D, internationally recognized for his research demonstrating the role of human papillomavirus as the etiological agent of cervical cancer, will receive the American Association of Cancer Research Award for Lifetime Achievement in honor of his life's work devoted to the st ...

read more Harald zur Hausen, D.Sc., M.D, internationally recognized for his research demonstrating the role of human papillomavirus as the etiological agent of cervical cancer, will receive the American Association of Cancer Research Award for Lifetime Achievement in honor of his life's work devoted to the st read more Tue Mar 2008 Tue Mar 2008

Research Publication On Immune Response To REOLYSIN During A Phase I Clinical Trial

Categorie : Cancer / Oncology
Dr. Kevin Harrington and team at The Institute of Cancer Research, London, U.K. published the results of their work characterizing immune system responses to administration of intravenous REOLYSIN® in a Phase I clinical trial. The paper, entitled "Characterization of the Adaptive and Innate Im ...

read more Dr. Kevin Harrington and team at The Institute of Cancer Research, London, U.K. published the results of their work characterizing immune system responses to administration of intravenous REOLYSIN® in a Phase I clinical trial. The paper, entitled read more Tue Mar 2008 Tue Mar 2008

Oral Cancer - PDA Stresses The Importance Of Early Detection

Categorie : Cancer / Oncology
Approximately 35,000 Americans are diagnosed with oral cancer each year and nearly 8,000 people died of these cancers in 2007 alone. Early detection is an integral part in battling the disease and can even help identify precancerous cells before they become cancerous. The Pennsylvania Dental Ass ...

read more Approximately 35,000 Americans are diagnosed with oral cancer each year and nearly 8,000 people died of these cancers in 2007 alone. Early detection is an integral part in battling the disease and can even help identify precancerous cells before they become cancerous. The Pennsylvania Dental Ass read more Tue Mar 2008 Tue Mar 2008

New Localized Cancer Treatment For Advanced Retinoblastoma Saves Children From Having Eyes Removed, Restores Vision In Some Cases

Categorie : Cancer / Oncology
A new interventional radiology treatment successfully treats advanced retinoblastoma -- a deadly, inherited cancer of one or both eyes in children -- and often spares them from having their eyes surgically removed (enucleated), according to the results of a study released today at the Society of I ...

read more A new interventional radiology treatment successfully treats advanced retinoblastoma -- a deadly, inherited cancer of one or both eyes in children -- and often spares them from having their eyes surgically removed (enucleated), according to the results of a study released today at the Society of I read more Tue Mar 2008 Tue Mar 2008

Interventional Cryoablation Stops Cancer Cold Curative Option For Patients With Small Localized Kidney Tumors

Categorie : Cancer / Oncology
Two papers presented at the Society of Interventional Radiology's 33rd Annual Scientific Meeting show that cryoablation -- the minimally invasive interventional radiology treatment to freeze primary kidney tumors without surgery -- is 95 percent effective when the tumors are four centimeters or smal ...

read more Two papers presented at the Society of Interventional Radiology's 33rd Annual Scientific Meeting show that cryoablation -- the minimally invasive interventional radiology treatment to freeze primary kidney tumors without surgery -- is 95 percent effective when the tumors are four centimeters or smal read more Tue Mar 2008 Tue Mar 2008

Tumor Markers Can Show Presence Or Absence Of Testicular Cancer, But Are Not Used In A Majority Of Patients

Categorie : Cancer / Oncology
A standard part of testicular cancer care isn't used in more than half of all patients who have the condition, researchers at the University of Michigan Comprehensive Cancer Center have found.Serum-based tumor markers, which are one indicator of the presence of cancer cells, are helpful in several a ...

read more A standard part of testicular cancer care isn't used in more than half of all patients who have the condition, researchers at the University of Michigan Comprehensive Cancer Center have found.Serum-based tumor markers, which are one indicator of the presence of cancer cells, are helpful in several a read more Tue Mar 2008 Tue Mar 2008

MU Laser Lab Will Enable Researchers To Change The Face Of Medicine

Categorie : Cancer / Oncology
Many people equate lasers with a sci-fi battle in a galaxy far, far away or, closer to home, with grocery store scanners and compact disc players. However, an ultra-fast, ultra-intense laser, or UUL, with laser pulse durations of one quadrillionth of a second, otherwise known as one femtosecond, cou ...

read more Many people equate lasers with a sci-fi battle in a galaxy far, far away or, closer to home, with grocery store scanners and compact disc players. However, an ultra-fast, ultra-intense laser, or UUL, with laser pulse durations of one quadrillionth of a second, otherwise known as one femtosecond, cou read more Mon Mar 2008 Mon Mar 2008

Parkinson's Disease Drug Might Work In Cancer Patients

Categorie : Cancer / Oncology
A study published in the March 13 online issue of The Journal of Clinical Investigation shows that dopamine, a drug currently used to treat Parkinson's disease and other illnesses, also might work in cancer patients. The study, which was done in mouse and laboratory models, shows that dopamine could ...

read more A study published in the March 13 online issue of The Journal of Clinical Investigation shows that dopamine, a drug currently used to treat Parkinson's disease and other illnesses, also might work in cancer patients. The study, which was done in mouse and laboratory models, shows that dopamine could read more Mon Mar 2008 Mon Mar 2008

Preventing Spread Of Ovarian Cancer

Categorie : Cancer / Oncology
A drug that blocks production of an enzyme that enables ovarian cancer to gain a foothold in a new site can slow the spread of the disease and prolong survival in mice, according to a study by researchers from the University of Chicago Medical Center, but only if the drug is given early in the disea ...

read more A drug that blocks production of an enzyme that enables ovarian cancer to gain a foothold in a new site can slow the spread of the disease and prolong survival in mice, according to a study by researchers from the University of Chicago Medical Center, but only if the drug is given early in the disea read more Mon Mar 2008 Mon Mar 2008

Celsion Commences Global Phase III Study For Primary Liver Cancer

Categorie : Cancer / Oncology
Celsion Corporation (NASDAQ: CLN) announced that two clinical sites are currently screening patients after receiving IRB approval for the Phase III study titled "A Phase III, Randomized, Double-Blinded, Dummy-Controlled Study of the Efficacy and Safety of ThermoDox® (Thermally Sensitive Liposomal D ...

read more Celsion Corporation (NASDAQ: CLN) announced that two clinical sites are currently screening patients after receiving IRB approval for the Phase III study titled read more Mon Mar 2008 Mon Mar 2008

Misonix CEO Announces HIFU Strategy Targeting Cancer Therapy

Categorie : Cancer / Oncology
Misonix, Inc. (Nasdaq: MSON), a developer of minimally invasive ultrasonic medical device technology for the treatment of cancer and other chronic health conditions, issued today the first formal statement from its Chief Executive Officer Michael A. McManus, Jr. regarding the Company's High Intensit ...

read more Misonix, Inc. (Nasdaq: MSON), a developer of minimally invasive ultrasonic medical device technology for the treatment of cancer and other chronic health conditions, issued today the first formal statement from its Chief Executive Officer Michael A. McManus, Jr. regarding the Company's High Intensit read more Mon Mar 2008 Mon Mar 2008

Allovectin-7(R) May Offer Patients A New Option For Advanced Melanoma

Categorie : Cancer / Oncology
Skin cancer specialists at the Huntsman Cancer Institute at the University of Utah are recruiting patients into a large Phase 3 study to evaluate the safety and effectiveness of Allovectin-7®, an investigational product for advanced melanoma. If Allovectin-7® is found to be safe and effective in cli ...

read more Skin cancer specialists at the Huntsman Cancer Institute at the University of Utah are recruiting patients into a large Phase 3 study to evaluate the safety and effectiveness of Allovectin-7®, an investigational product for advanced melanoma. If Allovectin-7® is found to be safe and effective in cli read more Mon Mar 2008 Mon Mar 2008

Arrowhead Subsidiary, Calando Pharmaceuticals, Submits IND For Clinical Trial With Targeted, Nano-Delivered RNAi Therapeutic For Cancer

Categorie : Cancer / Oncology
Arrowhead Research Corporation (NASDAQ:ARWR) announced that its majority owned subsidiary, Calando Pharmaceuticals, a leading siRNA therapeutics company, submitted an investigational new drug application (IND) to the U.S. Food and Drug Administration to initiate a Phase I clinical trial using their ...

read more Arrowhead Research Corporation (NASDAQ:ARWR) announced that its majority owned subsidiary, Calando Pharmaceuticals, a leading siRNA therapeutics company, submitted an investigational new drug application (IND) to the U.S. Food and Drug Administration to initiate a Phase I clinical trial using their read more Mon Mar 2008 Mon Mar 2008

New Study Shows Colorectal Cancer Screening Rates Increasing Among U.S. Adults

Categorie : Cancer / Oncology
The percentage of U.S. adults aged 50 years and older getting screened for colorectal cancer is increasing according to a study released by the Centers for Disease Control and Prevention's (CDC) Morbidity and Mortality Weekly Report. The study uses state-level Behavioral Risk Factor Surveillance Sur ...

read more The percentage of U.S. adults aged 50 years and older getting screened for colorectal cancer is increasing according to a study released by the Centers for Disease Control and Prevention's (CDC) Morbidity and Mortality Weekly Report. The study uses state-level Behavioral Risk Factor Surveillance Sur read more Mon Mar 2008 Mon Mar 2008

A Tumor Of The Pancreas Mimicked By Colonic Duplication?

Categorie : Cancer / Oncology
A case of cystic colonic duplication in an adult mimicked a tumor of the pancreas and the diagnosis was established by histopathological examination of the resected specimen after distal pancreatectomy.This report performed by a team led by Dra. Fabiana P Carneiro, is described in a case report to b ...

read more A case of cystic colonic duplication in an adult mimicked a tumor of the pancreas and the diagnosis was established by histopathological examination of the resected specimen after distal pancreatectomy.This report performed by a team led by Dra. Fabiana P Carneiro, is described in a case report to b read more Mon Mar 2008 Mon Mar 2008

Possible Long-Term Survival Offered By Resection Of Solid-Pseudopapillary Tumor Of The Pancreas

Categorie : Cancer / Oncology
The article published in volume 14 issue 6 of World Journal of Gastroenterology reports on one patient who presented to Dr Cosimo Sperti of University of Padua, Padova, Italy, in 2001 after an exploratory laparotomy performed in another hospital for an unresectable pancreatic cystic mass that had in ...

read more The article published in volume 14 issue 6 of World Journal of Gastroenterology reports on one patient who presented to Dr Cosimo Sperti of University of Padua, Padova, Italy, in 2001 after an exploratory laparotomy performed in another hospital for an unresectable pancreatic cystic mass that had in read more Mon Mar 2008 Mon Mar 2008

<<< previous | 1 | 2 | 3 | 4 | 5 | 6 next >>>



     


Custom Search